[Pharmaceutical Bio News] Hyundai Bioscience to Begin Clinical Trials for Dengue Treatment in Vietnam on the 30th
Hyundai Bioscience is set to begin clinical trials for a universal antiviral treatment for dengue and similar diseases in Vietnam on March 30.
Hyundai ADM Bio Changes Name to 'Penetrum Bioscience'
Hyundai ADM Bio has changed its name to Penetrum Bioscience to reflect its focus on developing a new drug candidate, 'Penetrum.'
Hyundai BioScience launches global clinical trial for 'universal dengue treatment' in Vietnam
Hyundai BioScience has initiated a global clinical trial for a dengue and similar disease treatment in Vietnam, marking a significant step in addressing tropical infectious diseases with no existing effective treatments.